Heel medicines are available in 50 countries worldwide. Choose your country below to learn more.
Winners of the Hans-Heinrich Reckeweg Clinical Case Award 2017The Main Award for this year’s Hans-Heinrich Reckeweg Clinical Case Award was presented to Tamar Mosulishvili and Nataliia Sydorova for their submission “Case-report of effective treatment of acute unilateral undifferentiated tinnitus with a bioregulatory medicine preparation”. The runner-up award went to Nora Álvarez Upegui for her case report on “Therapeutic Success of Bioregulatory Systems Medicine in Varicose Ulcer. Multiple conventional treatments without clinical improvement”. More on the Hans-Heinrich Reckeweg Clinical Case Award 2017
Press releaseHeel’s Traumeel® and Zeel® T shown to reduce pain of OA of the knee by more than 60% in MOZArT trial - Clinical data released at the 2015 European League Against Rheumatism (EULAR) congress show Traumeel® and Zeel® T co-administered intra-articular (IA) injections provide a new first line injection treatment option in the management of moderate to severe osteoarthritis of the knee, where oral pain management failed. More press releases